Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 2Phase 3 1

Status

Active not recruiting 3Terminated 2Completed 2

Sponsor Class

INDUSTRY 4OTHER 2NETWORK 1

Study Type

Interventional 7

Sponsor

Cancer Type

Plasma cell 5Lymphoid 2Other hematologic neoplasm 1Other 1Gastrointestinal 1

Conditions

Multiple Myeloma 4Recurrence 1Purpura 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Nausea 1Macroglossia 1Lymphoma 1Lymphadenopathy 1Leukemia, Myeloid, Acute 1Immunoglobulin Light-chain Amyloidosis 1Hepatomegaly 1Gastrointestinal Hemorrhage 1Diarrhea 1Constipation 1

Interventions

pembrolizumab 302Carboplatin 155Nivolumab 154Cisplatin 139Cyclophosphamide 130Paclitaxel 127Magnetic Resonance Spectroscopy 98Specimen Handling 95Radiotherapy 90Gemcitabine 87Dexamethasone 83Biopsy 81Ipilimumab 78Docetaxel 75Doxorubicin 75Rituximab 69Etoposide 67atezolizumab 61durvalumab 60Lenalidomide 59Radiation 59Pemetrexed 58Taxes 57Bevacizumab 54Prednisone 54fludarabine 54olaparib 53Cytarabine 49Vincristine 49Fluorouracil 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Has results × isatuximab × 1 year × Clear all
NCT04430894 2026-06-03

KRDI in Transplant-Eligible MM

Massachusetts General Hospital

Phase 2 Active not recruiting
50 enrolled 20 charts
Plasma cell

Multiple Myeloma

NCT05911321 2026-05-20

Isa-Pom-Dex in Elderly/Frail Subjects With RRMM

UNC Lineberger Comprehensive Cancer Center

Phase 2 Active not recruiting
6 enrolled 5 charts
Plasma cell

Multiple Myeloma, Recurrence

NCT04126200 2026-05-06

DREAMM 5

GlaxoSmithKline

Phase 1/2 Active not recruiting
208 enrolled 5 charts
Plasma cell

Multiple Myeloma

NCT03275285 2026-02-09

IKEMA

Sanofi

Phase 3 Completed
302 enrolled 38 charts 1 FDA
Plasma cell

Multiple Myeloma

NCT03769181 2025-09-23

A Study of Isatuximab-based Therapy in Participants With Lymphoma

Sanofi

Phase 1/2 Terminated
58 enrolled 37 charts
Lymphoid

Lymphoma

NCT03499808 2025-09-09

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

SWOG Cancer Research Network

Phase 2 Completed
43 enrolled 23 charts
GastrointestinalOtherPlasma cell

Lymphadenopathy, Immunoglobulin Light-chain Amyloidosis, Constipation, Diarrhea, Gastrointestinal Hemorrhage, Hepatomegaly, Macroglossia, Nausea, Purpura

NCT03860844 2025-09-09

ISAKIDS

Sanofi

Phase 2 Terminated
67 enrolled 25 charts
LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡